A Study of KITE-363 in Participants With Refractory Autoimmune Diseases

NCT07038447 · clinicaltrials.gov ↗

PHASE1

Phase

ENROLLING_BY_INVITATION

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus
Lupus Nephritis
Systemic Sclerosis
Idiopathic Inflammatory Myopathy

Interventions

BIOLOGICAL: KITE-363
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Kite, A Gilead Company